PAR-24-080: Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2023.
National Institutes of Health offered grants of up to $1.5 million to small businesses. Applications closed on March 24, 2025.
From the official notice on Grants.gov, last changed March 24, 2025. Checked November 7, 2026.
- Award ceiling$1.5 million
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeP30
- Clinical trialsNot allowed
- Funded byNIAID
- Median yearly award$610,084
- Typical project length24.5 years
- P30, Center Core Grant. Shared facilities and services for investigators who already hold research funding on a common theme. Other open P30 notices.
Projects funded under PAR-24-080 were run by National Institute of Allergy and Infectious Diseases (NIAID, 9 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read PAR-24-080 in the NIH Guide.
Key dates
| Posted | December 20, 2023 |
|---|---|
| Deadline | March 24, 2025 |
| Archived by Grants.gov | March 25, 2025 |
Who can apply
This opportunity was open to small businesses.
- Small businesses
Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Is this a realistic fit?
- Projects NIH funded under this notice had a median yearly award of $610,084; it allows up to $1.5 million per award.
- Most of the program's money (67% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
Not Available
Funded under PAR-24-080 so far
NIH funded 9 projects under PAR-24-080 in fiscal 2024 to 2026, at 9 institutions. The median yearly award was $610,084.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Developmental Core Revision | University of Washington | 2026 | $1.0 million |
| Center for AIDS Research at Emory University-CFAR RYSE Pathway Programs | Emory University | 2025 | $1.4 million |
| Third Coast Center for AIDS Research | Northwestern University | 2024 | $1.2 million |
| DC CFAR Administrative Core | George Washington University | 2024 | $503,417 |
| Core C Uganda | Case Western Reserve University | 2024 | $959,560 |
| The University of North Carolina Center for AIDS Research | Univ of North Carolina Chapel Hill | 2024 | $447,280 |
| The CFAR Diversity, Equity, and Inclusion Pathway Initiative to Support The Continued Development of Generation Tomorrow (JHU CFAR Supplement) | Johns Hopkins University | 2024 | $610,084 |
| Texas Developmental Center for AIDS Research | Baylor College of Medicine | 2024 | $451,866 |
Who has won Allergy and Infectious Diseases Research grants before
From fiscal 2021 to 2025, Allergy and Infectious Diseases Research (93.855) awarded $22 billion across 13,282 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Fred Hutchinson Cancer Center | Washington | 85 | $938 million |
| Duke University | North Carolina | 230 | $781 million |
| University of California, Los Angeles | California | 138 | $745 million |
| The Johns Hopkins University | Maryland | 321 | $668 million |
| Emory University | Georgia | 282 | $650 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PAR-24-080 still open?
No. It closed on March 24, 2025.
Who can apply for Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)?
Closed March 24, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.5 million each.
Who has been funded under PAR-24-080?
NIH RePORTER lists 9 projects funded under PAR-24-080 in fiscal 2024 to 2026, at 9 institutions. The most were at University of Washington, Emory University, Northwestern University.
Who has won Allergy and Infectious Diseases Research grants before?
The largest recipients over five fiscal years were Fred Hutchinson Cancer Center, Duke University, University of California, Los Angeles. The program made 13,282 awards worth $22 billion in that time.
Similar open grants
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- KUH P30 Resource Core Center (P30 Clinical Trial Not Allowed)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
- AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)